Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally.
Fibrosis predicts post-surgical risk in aortic stenosis, reinforcing its role in guiding treatment decisions for both sexes.
4d
News Medical on MSNNew drug ataciguat shows promise for managing aortic valve stenosisAortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally.
Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers are exploring the use of a new drug called ataciguat to manage ...
2d
Tribune Content Agency on MSNThe Medicine Cabinet: Ask the Harvard Experts: Why an aortic valve can narrow and impede blood flowQ: My doctor heard a new heart murmur and suspected I have a narrowed valve due to aortic stenosis. I feel fine. Why did this ...
3d
Medpage Today on MSNAtaciguat's Headway in Aortic Stenosis; Baby Pacemakers; AI-ECG Tool for the ED?The nitric oxide-independent soluble guanylate cyclase activator ataciguat continued to show promise for slowing the ...
Audio Research’s self-declared "finest-ever power amplifier" is now shipping worldwide and it is the culmination of 55 years at the very cutting edge of valve amp design. What you're looking at ...
Recurrent pulmonary vein stenosis (PVS) following surgical repair of total anomalous pulmonary venous connection is associated with poor prognosis. Preclinical studies have shown that use of an ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results